Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Osteoporosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    November 2017
  1. HARVEY NC, McCloskey E, Kanis JA, Compston J, et al
    Bisphosphonates in osteoporosis: NICE and easy?
    Lancet. 2017;390:2243-2244.
    PubMed     Text format    


  2. FERRARI SL
    Prevention of fractures in patients with osteoporosis.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32167.
    PubMed     Text format    


  3. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    PubMed     Text format     Abstract available


    July 2017
  4. LANGDAHL BL, Libanati C, Crittenden DB, Bolognese MA, et al
    Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
    Lancet. 2017 Jul 26. pii: S0140-6736(17)31613.
    PubMed     Text format     Abstract available


  5. COMPSTON J
    Bone-forming agents in non-responders to bisphosphonates.
    Lancet. 2017 Jul 26. pii: S0140-6736(17)31824.
    PubMed     Text format    


    August 2016
  6. CLARK W, Bird P, Gonski P, Diamond TH, et al
    Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Aug 17. pii: S0140-6736(16)31341.
    PubMed     Text format     Abstract available


    November 2015
  7. GNANT M
    Denosumab and fracture risk in women with breast cancer - Author's reply.
    Lancet. 2015;386:2057-8.
    PubMed     Text format    


  8. BOISSIEU PD, Trenque T
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2057.
    PubMed     Text format    


  9. FAROOKI A, Fornier M
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2056-7.
    PubMed     Text format    


    July 2015
  10. BRUFSKY A, Mathew A
    Bisphosphonates, bone, and breast cancer recurrence.
    Lancet. 2015 Jul 23. pii: S0140-6736(15)61163.
    PubMed     Text format    



  11. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
    Lancet. 2015 Jul 23. pii: S0140-6736(15)60908.
    PubMed     Text format     Abstract available


  12. LEDER BZ, Tsai JN, Uihlein AV, Wallace PM, et al
    Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
    Lancet. 2015 Jul 2. pii: S0140-6736(15)61120.
    PubMed     Text format     Abstract available


  13. HOFBAUER LC, Rachner TD
    More DATA to guide sequential osteoporosis therapy.
    Lancet. 2015 Jul 2. pii: S0140-6736(15)61175.
    PubMed     Text format    


    May 2015
  14. WATTS G
    Frans Stephanus Hough.
    Lancet. 2015;385:2146.
    PubMed     Text format    


  15. COLEMAN R, Hadji P
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015 May 29. pii: S0140-6736(15)61032.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: